Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 547 Carcinoma, Non-Small-Cell Lung 506 Prostatic Neoplasms 332 Colorectal Neoplasms 270 Multiple Myeloma 266 Neoplasms 260 Leukemia, Myeloid, Acute 221 Squamous Cell Carcinoma of Head and Neck 213 Lung Neoplasms 206 Neoplasm Metastasis 203 Carcinoma, Hepatocellular 196 Melanoma 172 Triple Negative Breast Neoplasms 171 Pancreatic Neoplasms 170 Recurrence 152 Ovarian Neoplasms 149 Lymphoma 139 Brain Neoplasms 132 Glioblastoma 131 Sarcoma 130 Carcinoma, Renal Cell 126 Leukemia, Lymphocytic, Chronic, B-Cell 124 Head and Neck Neoplasms 124 Stomach Neoplasms 122 Lymphoma, Large B-Cell, Diffuse 122 Rectal Neoplasms 107 Precursor Cell Lymphoblastic Leukemia-Lymphoma 105 Myelodysplastic Syndromes 102 Uterine Cervical Neoplasms 100 Urinary Bladder Neoplasms 100

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hospice × 1 year × Clear all

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡